Bayer exec urges EU to avoid trade war as pharma dodges tariffs (for now)

Bayer’s head of Pharmaceuticals talks to Euractiv about US tariffs, expresses scepticism over CMA, and how the discussion on RDP should be focused on increasing it for incentivising competitiveness.